IMRALDI sol inj 40 mg/0.4ml stylo pré 6 x 0.4 ml

7680675820061 CH-67582 L04AB04 07.15.0.

Reimbursement limitations:

IMRALDI3

Substitution préparation de référence/biosimilaire
Le traitement par IMRALDI exige une garantie préalable de prise en …

IMRALDI sol inj 40 mg/0.4ml stylo pré 6 x 0.4 ml
IMRALDI sol inj 40 mg/0.4ml stylo pré 6 x 0.4 ml
IMRALDI sol inj 40 mg/0.4ml stylo pré 6 x 0.4 ml
1 / 3
google

Details

Product number
6758202
CPT
-
Packaging group
6
Unit
Injektor(en), vorgefüllt/Pen
Composition
adalimumabum 40 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum succinicum, dinatrii succinas, histidinum, histidini hydrochloridum monohydricum, mannitolum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.08 mg.

Articles (1)

Imraldi 40 mg/0.4 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
6
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/06/2025
Patient information leaflet
Français
18/06/2025
Patient information leaflet
Italien
18/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.08 MG Substance HBESI

Reimbursement information

Public price
CHF 2281.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2025

Authorization holder

Samsung Bioepis CH GmbH

6005 Luzern

Authorization information

Swissmedic authorization number
67582
Drug name
Imraldi, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
L04AB04
Authorization status
Z
Dispensation category
B
First authorization
03/04/2020
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, polyartikuläre juvenile idiopathische Arthritis, psoriatische Arthritis, ankylosierende Spondylitis (Morbus Bechterew), Morbus Crohn bei Erwachsenen, ulcerative Colitis, Plaque Psoriasis bei Erwachsenen, Hidradenitis suppurativa

Packaging details

Description (FR)
IMRALDI sol inj 40 mg/0.4ml stylo pré 6 x 0.4 ml
Description (DE)
IMRALDI Inj Lös 40 mg/0.4ml Fertpen 6 x 0.4 ml
Market launch
18/12/2024
Narcotic (BTM)
No

Other packaging sizes

IMRALDI sol inj 40 mg/0.8ml stylo pré 0.8 ml
1 INJ
View
IMRALDI sol inj 40 mg/0.8ml stylo pré 2 x 0.8 ml
2 INJ
View
IMRALDI sol inj 40 mg/0.8ml stylo pré 6 x 0.8 ml
6 INJ
View
IMRALDI sol inj 40 mg/0.4ml stylo pré 0.4 ml
1 INJ
View
IMRALDI sol inj 40 mg/0.4ml stylo pré 2 x 0.4 ml
2 INJ
View